Add Company
Join Now

Endonovo Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Endonovo Therapeutics's estimated annual revenue is currently $930k per year.(i)
  • Endonovo Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Endonovo Therapeutics has 6 Employees.(i)
  • Endonovo Therapeutics grew their employee count by 0% last year.

Endonovo Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
President and Chief Commercial OfficerReveal Email/Phone
3
Director Sales and MarketingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Endonovo Therapeutics?

Endonovo Therapeutics (OTCQB: ENDV) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. Endonovo's Immunotronicsâ„¢ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. Endonovo's Cytotronicsâ„¢ platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M620%N/A
#2
$0.7M7-12%N/A
#3
$0.7M7-12%N/A
#4
$0.7M70%N/A
#5
$0.5M70%N/A